Tag : urrogate biomarkers

Clinical Research, Pharma & Healthcare Financing

Health Canada Approves 4Moving Biotech’s Phase 2a OA Trial

Business Wire
by Business Wire0101
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatment that modify the natural history of knee osteoarthritis, announces that it has been...